Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

Dr Robert Zeman Receives Thorwarth Award for Radiology Leadership

Dr Robert Zeman: The American College of Radiology® (ACR®) Economics and Health Policy Department today announced Robert Zeman, MD, FACR, FSAR, as the 2022 recipient of the William T. Thorwarth Jr., MD, Award at ACR 2022®, the College’s annual meeting in Washington, DC.

This honor recognizes individuals who demonstrate outstanding contributions to the field of health policy and economics for radiology. Dr. Zeman is a Professor and Chairman of Radiology and Radiation Oncology at the George Washington University School of Medicine.

“Dr Robert Zeman’s contributions within the ACR, specifically his commitment to the Contractor Advisory Committee Network, as well as his involvement at the Centers for Medicare and Medicaid Services (CMS) and other organizations, has helped amplify the voice of radiology,” said Gregory Nicola, MD, FACR, Chair of the ACR Commission on Economics. “He continues to give back by educating future generations of radiologists and I am honored to present him with this prestigious award.”

Dr Robert Zeman is receiving the award for 17 years of dedicated service in various capacities on the ACR Commission on Economics, including Chair of the Contractor Advisory Committee Network. He was an integral voice in national and local Medicare coverage determinations for many imaging services, including computed tomography, magnetic resonance imaging and positron emission tomography policies. Dr. Zeman served as a voting member of the CMS Medicare Evidence Development and Coverage Advisory Committee Panel for four years.

The William T. Thorwarth Jr., MD, Award was established in 2004 by the ACR Commission on Economics to honor members or staff who show excellence in the field of economics and health policy by way of leadership, diplomacy and integrity.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy